|
|
Volumn 98, Issue 20, 2006, Pages 1443-1444
|
|
Epigenetic cancer therapy makes headway.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 AZA 2' DEOXYCYTIDINE;
ANTINEOPLASTIC AGENT;
AZACITIDINE;
DRUG DERIVATIVE;
HISTONE DEACETYLASE;
HYDROXAMIC ACID;
METHYLTRANSFERASE;
VALPROIC ACID;
VORINOSTAT;
ACETYLATION;
ANIMAL;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DNA METHYLATION;
DRUG EFFECT;
GENE EXPRESSION REGULATION;
GENETIC EPIGENESIS;
GENETICS;
HUMAN;
NEOPLASM;
RANDOMIZED CONTROLLED TRIAL;
ACETYLATION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
AZACITIDINE;
DNA METHYLATION;
EPIGENESIS, GENETIC;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HISTONE DEACETYLASES;
HUMANS;
HYDROXAMIC ACIDS;
METHYLTRANSFERASES;
NEOPLASMS;
RANDOMIZED CONTROLLED TRIALS;
VALPROIC ACID;
|
|
EID: 33750596313
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djj447 Document Type: Article |
|
Times cited : (103)
|
|
References (0)
|
